<DOC>
	<DOCNO>NCT00818493</DOCNO>
	<brief_summary>This Phase 2 3-arm , open label pilot study safety efficacy Q8003 patient undergone primary unilateral total knee arthroplasty total hip arthroplasty .</brief_summary>
	<brief_title>Pilot Study Efficacy Safety Q8003 Patients Who Have Undergone Total Knee Arthroplasty Total Hip Arthroplasty</brief_title>
	<detailed_description>This Phase 2 study 3 arm , open-label pilot study evaluate : - analgesic efficacy flexible ascend regimen Q8003 compare low dose regimen Q8003 ( 3 mg/2 mg potentially 6 mg/ 4mg ) 1-2 Percocet® 5 mg/325 mg tablet . Study drug administer every 4-6 hour 48-hour Treatment Period inpatient moderate severe postoperative pain undergone primary unilateral total knee arthroplasty total hip arthroplasty . - flexible ascend regimen Q8003 treatment group , evaluate adequacy algorithm conversion IV PCA morphine oral morphine equivalent dose Q8003 . - safety flexible ascend regimen Q8003 administer 48-hour Treatment Period .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Acetaminophen , hydrocodone drug combination</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Male female , least 18 year age time enrollment . If female , least one year postmenopausal , surgically sterile practice effective contraception , nonlactating , childbearing potential , negative urine pregnancy test result . Have body mass index ( BMI ) 38 kg/m2 less . Have undergone primary unilateral total knee arthroplasty total hip arthroplasty perform standardized general , spinal epidural anesthesia . Have develop moderate severe pain ( score 2 4 point Likert scale least 4 11 point NPRS scale within 6 hour discontinue PCA morning surgery ) . In opinion Investigator , history pulmonary , cardiovascular ( include uncontrolled hypertension ) , neurologic , endocrine , hepatic , gastrointestinal , kidney disease therapy , opinion Investigator , would jeopardize patient 's well participation study mentally emotionally unsuitable participate , unable/unwilling comply study assessment . Used opiates continuously ( include tramadol ) ten day past year . Hypersensitivity poor tolerance ibuprofen short term opioids . Currently receive medication stable dose ( dose &gt; 2 month prior date surgery ) . Was dose another investigational drug within 30 day prior Screening Visit previously receive treatment Q8003 . Current therapy central nervous system depressant medication might increase risk treatment opioids ( used surgical anesthesia ) . Current evidence alcohol abuse ( regularly drink 4 unit alcohol per day ; 1 unit = ½ pint beer , 1 glass wine , 1 ounce spirit ) . History abuse licit illicit drug substance within five ( 5 ) year study entry . Has take drug know interact morphine oxycodone metabolism , include , limited , phenothiazine , monoamine oxidase inhibitor ( MAOI ) , amphetamine , muscle relaxant within 4 week prior date surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>total knee arthroplasty</keyword>
	<keyword>total hip arthroplasty</keyword>
</DOC>